DTIL

#3227
Precision BioSciences, Inc. - Common Stock
6.9 7 USD
-0.14%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
6.97
6.97
Year Range
3.53
8.82
Daily Change
-0.14%
Monthly Change
+0.87%
6 month change
+28.12%
Year Change
+41.38%
Previous Close
6.9 8
Open
6.9 7
Low
6.9 7
High
6.9 7
Volume
34
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 179.84 M
  • Employee 66
  • Founded 2006
  • CEO N/A
  • Website www.precisionbiosciences.com
  • Headquarter Delaware, United States
  • FIGI BBG008NSBPV3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.62
Price to sales ratio
1.77

Precision BioSciences, Inc. - Common Stock

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

News